Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer
for
Breast Cancer
Location: Philadelphia PA
Sponsor: Thomas Jefferson University
Sex: Female
Age: 18+
Code: NCT01514565
Recruiting
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Boston MA, St Louis MO
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07137416
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now